4//SEC Filing
HI TECH PHARMACAL CO INC 4
Accession 0001566028-13-000036
CIK 0000887497operating
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 2:58 PM ET
Size
17.0 KB
Accession
0001566028-13-000036
Insider Transaction Report
Form 4
April Gary M
President, HCP Division
Transactions
- Exercise/Conversion
Common Stock
2013-12-13$22.25/sh+1,874$41,697→ 3,749 total - Sale
Common Stock
2013-12-13$43.06/sh−6,873$295,951→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-12-13−3,124→ 9,376 totalExercise: $31.93From: 2013-11-08Exp: 2022-11-08→ Common Stock (3,124 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2013-12-13−1,874→ 1,876 totalExercise: $22.25From: 2011-11-10Exp: 2020-11-10→ Common Stock (1,874 underlying) - Exercise/Conversion
Common Stock
2013-12-13$19.59/sh+1,875$36,731→ 1,875 total - Exercise/Conversion
Common Stock
2013-12-13$31.93/sh+3,124$99,749→ 6,873 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-12-13−1,875→ 0 totalExercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (1,875 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $43.07, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
- [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
- [F3]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2012 Incentive Compensation Plan, which is a Rule 16b-3 Plan.
- [F4]The options become exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- [F5]Other than the options to acquire 1,876 and 9,376 shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of an additional option to acquire 9,375 shares of Hi-Tech common stock (for total options to acquire 19,845 shares still held by Mr. April), which option was granted in July 2012.
Documents
Issuer
HI TECH PHARMACAL CO INC
CIK 0000887497
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000887497
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 2:58 PM ET
- Size
- 17.0 KB